ASCOLI, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 253
EU - Europa 111
AS - Asia 83
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 451
Nazione #
US - Stati Uniti d'America 251
SG - Singapore 72
IT - Italia 67
SE - Svezia 18
GB - Regno Unito 12
TR - Turchia 3
AT - Austria 2
CN - Cina 2
CO - Colombia 2
CZ - Repubblica Ceca 2
DE - Germania 2
ES - Italia 2
FR - Francia 2
KR - Corea 2
MX - Messico 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BE - Belgio 1
BG - Bulgaria 1
CL - Cile 1
IL - Israele 1
IN - India 1
RU - Federazione Russa 1
UA - Ucraina 1
Totale 451
Città #
Chandler 64
Singapore 45
Lawrence 16
Milan 16
Princeton 16
Chicago 11
London 11
Wilmington 11
Ashburn 9
Genoa 8
Boardman 6
Des Moines 4
West Jordan 4
Busto Arsizio 3
Catania 3
Ferrara 3
Malatya 3
Mission 3
Padova 3
Valmadrera 3
Angri 2
Assago 2
Hanover 2
León 2
Louisville 2
Montesilvano Marina 2
Nakhon Sawan 2
Olomouc 2
Romainville 2
Rome 2
Seoul 2
Zacatecas City 2
Ann Arbor 1
Bologna 1
Brussels 1
Carmagnola 1
Cassano d'Adda 1
Catanzaro 1
Fano 1
Guangzhou 1
Kemerovo 1
Los Angeles 1
Norwalk 1
Rishon LeTsiyyon 1
Saint Louis 1
Santa Clara 1
Slough 1
Tremestieri Etneo 1
Vancouver 1
Vienna 1
Totale 284
Nome #
Predictive factors of Status Epilepticus and its recurrence in patients with adult–onset seizures: A multicenter, long follow–up cohort study 57
A comprehensive machine-learning-based software pipeline to classify EEG signals: A case study on PNES vs. control subjects 39
Management of status epilepticus in patients with liver or kidney disease: a narrative review 39
Perampanel as only add-on epilepsy treatment in elderly: A subgroup analysis of real-world data from retrospective, multicenter, observational study 32
Dystonia in Angelman syndrome: a common, unrecognized clinical finding 30
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST) 28
Epidemiology and outcomes of status epilepticus 26
Therapeutic approach to difficult-to-treat typical absences and related epilepsy syndromes 24
Connectivity measures suggest a sub-cortical generator of myoclonus in Angelman syndrome 21
Younger age at stroke onset but not thrombolytic treatment predicts poststroke epilepsy: An updated meta-analysis 20
Therapeutic approach to neurological manifestations of Angelman syndrome 19
Self-induced psychogenic non-epileptic seizure. A case report 17
Epileptogenic role of occult temporal encephalomeningocele 17
Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST) (CNS Drugs, (2021), 35, 12, (1289-1301), 10.1007/s40263-021-00856-3) 17
Effectiveness of Perampanel as the Only Add-on: Retrospective, Multicenter, Observational Real Life Study on epilepsy patients 16
Proprioceptive-induced seizures in non-ketotic hyperglycemia. A video-EEG documentation 14
Novel COL4A2 mutation causing familial malformations of cortical development 14
Diagnostic and therapeutic approach to drug-resistant juvenile myoclonic epilepsy 14
SMART: stroke-like migraine attacks after radiation therapy or seizures with migraine-like attacks after radiation therapy? Terms do matter in clinical practice 13
Functional convergence spasm: An unexpected finding in a patient with focal epilepsy 9
null 7
The relevance of MRI blood-sensitive sequences in the diagnostic assessment of late-onset epilepsy 6
Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study 3
Totale 482
Categoria #
all - tutte 5.918
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.918


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 3 0 0 6 0 0 0 2 7 1 0 0
2021/202268 0 0 3 22 1 0 3 14 8 7 7 3
2022/2023185 35 4 15 12 17 24 1 13 30 14 16 4
2023/2024105 17 16 3 12 6 17 8 2 1 6 8 9
2024/2025105 35 22 23 25 0 0 0 0 0 0 0 0
Totale 482